1-14 of 14
Albert Qin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis

Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, Norio Komatsu, John O. Mascarenhas, Weichung Joe Shih, Oleh Zagrijtschuk, Toshiaki Sato, Kazuya Shimoda, Richard T. Silver, Ruben A. Mesa
Journal: Blood
Blood (2024) 144 (Supplement 1): 3191.1.
https://doi.org/10.1182/blood-2024-200319
Published: 2024
Journal Articles

Treatment Patterns of Ropeginterferon Alfa-2b-Njft in the Real-World Setting

Hung-Lun Chien, Craig Zimmerman, Andrew Howe, Robert Geller, Albert Qin
Journal: Blood
Blood (2024) 144 (Supplement 1): 5184.
https://doi.org/10.1182/blood-2024-206228
Published: 2024
Journal Articles

Remarkable Molecular Response in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b

Shanshan Suo, Rongfeng Fu, Albert Qin, Zonghong Shao, Jie Bai, Hu Zhou, Na Xu, Suning Chen, Xuelan Zuo, Xin Du, Minghui Duan, Li Wang, Pei Li, Xuhan Zhang, Sujiang Zhang, Daoxiang WU, Jingjing Zhang, Weihong Shen, Wei Wang, Lei Zhang, Zhijian Xiao, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4562.
https://doi.org/10.1182/blood-2024-203148
Published: 2024
Journal Articles

Paradigm-PV: A Global, Randomized, Multicenter, Two-Arm Phase IV Study to Assess the Efficacy and Safety of Ropeginterferon Alfa-2b in Low- and High-Risk Patients with Polycythemia Vera

Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, Weichung Joe Shih, Waleed Da'na, Tsewang Tashi, Oleh Zagrijtschuk, Robert Geller, Harinder Gill
Journal: Blood
Blood (2024) 144 (Supplement 1): 6626.
https://doi.org/10.1182/blood-2024-199337
Published: 2024
Journal Articles

Incidence of Medical Conditions Associated with Polycythemia Vera Treatments

Hung-Lun Chien, Andrew Howe, Craig Zimmerman, Claudia Castro, Albert Qin, Robert Geller
Journal: Blood
Blood (2024) 144 (Supplement 1): 7938.
https://doi.org/10.1182/blood-2024-203859
Published: 2024
Journal Articles

Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database

Frank Snopek, Ali Seddighzadeh, Megan Flynn, Ling-Yu Cai, Esther Chen, Weichung Joe Shih, Albert Qin, Raymond W Urbanski
Journal: Blood
Blood (2023) 142 (Supplement 1): 6436.
https://doi.org/10.1182/blood-2023-190344
Published: 2023
Journal Articles

A Phase 3b, Randomized, Open-Label, Parallel Group, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera

John Mascarenhas, Tsewang Tashi, Firas El Chaer, Victor Priego, Oleh Zagrijtschuk, Albert Qin, Jewell Jessup, Craig Zimmerman, Ray Urbanski, Lucia Masarova
Journal: Blood
Blood (2023) 142 (Supplement 1): 6444.
https://doi.org/10.1182/blood-2023-189912
Published: 2023
Journal Articles

A Phase 3b, Single-Arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Ropeginterferon Alfa-2b-Njft (P1101) in Adult Patients with Polycythemia Vera

John Mascarenhas, Oleh Zagrijtschuk, Craig Zimmerman, Albert Qin, Raymond W Urbanski
Journal: Blood
Blood (2022) 140 (Supplement 1): 6748–6749.
https://doi.org/10.1182/blood-2022-162693
Published: 2022
Journal Articles

Phase Ⅱ,Open-Label, Multicenter, Single-Arm Study Investigating the Efficacy and Safety of Ropeginterferon Alfa-2b in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea(HU)

Jie Jin, Lei Zhang, Zonghong Shao, Jie Bai, Suning Chen, Minghui Duan, Sujiang Zhang, Hu Zhou, Na Xu, Xin Du, Xuelan Zuo, Li Wang, Pei Li, Xuhan Zhang, Daoxiang Wu, Yaning Li, Jingjing Zhang, Wei Wang, Warren Shen, Oleh Zagrijtschuk, Raymond Urbanski, Toshiaki Sato, Albert Qin, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 6858–6859.
https://doi.org/10.1182/blood-2022-165789
Published: 2022
Journal Articles

The Design of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Chinese Patients with Polycythemia Vera Resistant or Intolerant to Hydroxyurea (HU)

Jie Jin, Lei Zhang, Su-Jiang Zhang, Suning Chen, Ming-hui Duan, Jingjing Zhang, Wei Wang, Warren Shen, Oleh Zagrijtschuk, Raymond Urbanski, Albert Qin, Zhijian Xiao
Journal: Blood
Blood (2021) 138 (Supplement 1): 4628.
https://doi.org/10.1182/blood-2021-146449
Published: 2021
Journal Articles

Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia

Ruben A. Mesa, Norio Komatsu, Harinder Gill, Jie Jin, Sung-Eun Lee, Hsin-An Hou, Toshiaki Sato, Albert Qin, Raymond Urbanski, Weichung Shih, Oleh Zagrijtschuk, Craig Zimmerman, Srdan Verstovsek
Journal: Blood
Blood (2021) 138 (Supplement 1): 1491.
https://doi.org/10.1182/blood-2021-147417
Published: 2021
Journal Articles

The Rationale, Design, and Baseline Characteristics of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Japanese Patients with Polycythemia Vera for Whom the Current Standard of Care Is Difficult to Apply

Keita Kirito, MD, Kazuya Shimoda, MD PhD, Katsuto Takenaka, MD PhD, Albert Qin, MD PhD, Oleh Zagrijtschuk, MD, Toshiaki Sato, MD PhD, Narihisa Miyachi, Hiroaki Kawase, Katsuya Yonezu, Norio Komatsu, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-142504
Published: 2020
Journal Articles

Phase I Study of IMGN901, Used as Monotherapy, in Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Safety and Efficacy Analysis.

Asher Chanan-Khan, MD, Jeffrey Wolf, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD, Debbie Manfredi, Kelvin P. Lee, MD, Kena C Miller, NP, Robin Guild, Sybil Zildjian, MPH, Albert Qin, MD, Ph.D., James O'Leary, MD, Robert Vescio, MD
Journal: Blood
Blood (2009) 114 (22): 2883.
https://doi.org/10.1182/blood.V114.22.2883.2883
Published: 2009
Journal Articles

Phase I Study of IMGN901 in Patients with Relapsed and Relapsed/Refractory CD56-Positive Multiple Myeloma

Asher Alban Chanan-Khan, MD, Mecide Gharibo, MD, Sundar Jagannath, MD, Nikhil C. Munshi, MD, Kenneth C Anderson, MD, Dawn DePaolo, Kelvin P. Lee, MD, Kena Miller, RN, MSN, FNP, Robin Guild, Sybil Zildjian, Albert Qin
Journal: Blood
Blood (2008) 112 (11): 3689.
https://doi.org/10.1182/blood.V112.11.3689.3689
Published: 2008